Prospect Financial Services LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund purchased 2,471 shares of the exchange traded fund’s stock, valued at approximately $221,000. Other hedge funds have also recently bought and sold shares of the company. EPG Wealth Management […]
Coastwise Capital Group LLC boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 11.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,694 shares of the exchange traded fund’s stock after purchasing an additional 465 shares during […]
Sollinda Capital Management LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 2,677 shares of the exchange traded fund’s stock, valued at approximately $239,000. Several other hedge funds have also recently bought and sold shares of the company. BOCHK Asset […]
Sollinda Capital Management LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,677 shares of the exchange traded fund’s stock, valued at approximately $239,000. A number of […]
Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,444,444 shares of the exchange traded fund’s stock, valued at approximately $396,844,000. SPDR […]